1-3 of 3
Detlev Klemke
Close
Sort by
Journal Articles

Response Of Rare Variants Of Cutaneous T Cell Lymphoma (CTCL) To Treatment With Bexarotene. A Prospective German DeCOG Trial

Michael Weichenthal, MD, Simone Goldinger, MD, Ulrike Wehkamp, MD, Marc Beyer, MD, Annette Stein, MD, Athanasios Tsianakas, MD, André Koch, MD, Amir Yazdi, MD, Marion Wobser, MD, Yvonne Frambach, MD, Edgar Dippel, MD, Eva-Maria Geißler, MD, Carmen Loquai, MD, Peter Kurschat, MD, Claudia Pföhler, MD, Anke Hartmann, MD, Esther Coors, MD, Christian Hallermann, MD, Peter Mohr, MD, Uwe Hillen, MD, Benedetta Belloni, MD, Sandra Vogel, MD, Christina Mitteldorf, MD, Chalid Assaf, MD, Claus-Detlev Klemke, MD, Juergen C Becker, MD, Reinhard Dummer, MD, Jan Nicolay, MD
Journal: Blood
Blood (2013) 122 (21): 4379.
https://doi.org/10.1182/blood.V122.21.4379.4379
Published: 2013
Journal Articles

High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade

Michael K. Kießling, Patrick A. Oberholzer, Chandrani Mondal, Maria B. Karpova, Marie C. Zipser, William M. Lin, Michael Girardi, Laura E. MacConaill, Sarah M. Kehoe, Charlie Hatton, Lars E. French, Levi A. Garraway, Gernot Polier, Dorothee Süss, Claus-Detlev Klemke, Peter H. Krammer, Karsten Gülow, Reinhard Dummer
Journal: Blood
Blood (2011) 117 (8): 2433–2440.
https://doi.org/10.1182/blood-2010-09-305128
Published: 2011
Includes: Supplemental data
Journal Articles

T-cell clonality of undetermined significance

Edgar Dippel, Detlev Klemke, Michael Hummel, Harald Stein, Sergij Goerdt
Journal: Blood
Blood (2001) 98 (1): 247–248.
https://doi.org/10.1182/blood.V98.1.247
Published: 2001